The Trends of Uveal Melanoma Research in the Past Two Decades and Future Perspectives

被引:1
作者
Khaled Ali Elubous
Ali D. Alebous
Hebah A. Abous
Rawan A. Elubous
机构
[1] University of Jordan,Department of Ophthalmology
[2] King Hussein Cancer Center,Department of Surgery
[3] Jordanian Royal Medical Services,Department of Dermatology
[4] University of Jordan,Department of Radiology
关键词
Choroidal melanoma; Uveal melanoma; Trends; Bibliometric; Future perspectives; Analysis using software; Ocular oncology; COVID-19;
D O I
10.1007/s42399-021-01068-y
中图分类号
学科分类号
摘要
Evaluation of the research trends in uveal melanoma in the past two decades. Data were extracted from the Web of Science database website. VOSviewer and Citespace software were used to analyze the retrieved data. The leading country in terms of output and international collaboration is the USA. Research interest in genetic mutations, molecular pathways, and immunotherapy was remarkable in recent years. Most of the top ten journals are specialized in ophthalmology. In recent years, the hotspots include future perspectives, BAP1 mutation, therapeutic target, and systematic reviews. The keywords with the strongest citation bursts are immunotherapy, outcome, and in situ hybridization. The output of uveal melanoma research increased during the past two decades. Before 2015, the main focus of the research was to facilitate prognostication and metastatic risk stratification. Recently, research has moved to examine the metastatic microenvironment. Future research foci may include exploring the role of different mutations, immunotherapy, molecular alterations, and finding ideal clinical biomarkers.
引用
收藏
页码:2593 / 2602
页数:9
相关论文
共 141 条
  • [31] Luo A(2015)EMT-associated factors promote invasive properties of uveal melanoma cells Mol Vis 21 53-14
  • [32] Zhong Z(2019)Emerging roles and therapeutic value of exosomes in cancer metastasis Mol Cancer 18 1207-1093
  • [33] Van Raamsdonk CD(2014)Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma Int J Cancer 134 182-617
  • [34] Bezrookove V(2014)Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease Mol Immunol 58 1179-428
  • [35] Green G(2019)Pembrolizumab as first-line treatment for metastatic uveal melanoma Cancer Immunol Immunother 68 981-151
  • [36] Van Raamsdonk CD(2018)Survival Rates in patients after treatment for metastasis from uveal melanoma JAMA Ophthalmol 136 1-384
  • [37] Griewank KG(2014)Electronic address: paulfinger@eyecancer.com; ABS – OOTF Committee. The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma Brachytherapy 13 1085-686
  • [38] Crosby MB(2017)Uveal melanoma risk factors: a systematic review of meta-analyses Curr Eye Res 42 612-1360
  • [39] Singh AD(2005)Population-based incidence of uveal melanoma in various races and ethnic groups Am J Ophthalmol 140 419-undefined
  • [40] Turell ME(2004)Sunlight exposure and pathogenesis of uveal melanoma Surv Ophthalmol 49 145-undefined